Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: KanadaFázis nélkül

Neurolysis for the Treatment of Medial Chronic Knee Pain Due to Osteoarthritis

A legfontosabb adatok

Ki végzi
FUSMobile Inc.
Hol
North York (Kanada)A helyszín megnézése
Azonosító
Állapot
Toboroz
Résztvevők
10 fő, tervezett
Kezdés
2026. szept. 9.
Várható befejezés
2027. márc. 30.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • Neurotomy of the medial sensory articular branches
A regiszteradat frissítve
2026. november 9.

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 21 feltétel megnézéseKevesebb

Ki vehet részt

  • Moderate to severe, predominantly medial chronic knee pain
  • Age adult >18 years old
  • WOMAC Score of 30 or higher
  • NRS>6 with ambulation
  • Radiological confirmation of knee osteoarthritis (Kellgren-Lawrence Scale: 2-4)
  • Participants in whom the measured skin to bone depth is 2-6 cm using imaging ultrasound and ultrasound gel pad in the upper medial and lower medial joint capsule targets

Ki nem vehet részt

  • Individuals after any surgery associated with altered integrity of bone structure
  • Individuals with concomitant mental health disorders, excluding compensated mood disorders
  • Individuals who are scheduled for any interventional/surgical procedure within 3 months from the screening date, excluding trivial surgeries (e.g., cataract, skin tumors)
  • Individuals presenting with any severe medical condition preventing the participant from safely and effectively being treated in the study or reporting study outcomes, per PI decision
  • Symptomatic multifocal nociplastic chronic pain (e.g., fibromyalgia, generalized osteoarthritis) or any other chronic pain condition that could influence symptoms
  • Individuals meeting any of the following criteria are not eligible for participation in this study:
  • Individuals with severe pain in the second knee
  • Individuals unable to understand and complete the research questionnaires in the official language
  • Individuals with extensive scarring of the skin and tissue overlying the treatment area
  • Individuals enrolled in or planned to be enrolled in another clinical trial during the duration of this research project
  • Individuals with active inflammatory (e.g., rheumatoid) arthritis
  • Individuals with altered perception and processing of pain: Average NRS > 9, PCS>30, SSS-8 > 11, CSI>40 [46], [47], [48]
  • Individuals with a first-degree family member already enrolled in this study
  • Inability to attend follow-up visits and physiotherapy due to travel distance or other restrictions
  • Participants who have undergone radiofrequency ablation of the genicular nerves in the planned treatment limb within the preceding 6 months

Helyszínek itt: Kanada

  • Unika Medical CentreNorth York, KanadaContact: Melissa Diep, Research CoordinatorRésztvevőt keres

A vizsgálatról

Mit akar kideríteni a vizsgálat

This study involves the use of sound waves to block pain signals caused by osteoarthritis of the knee. The sound waves are tightly focused on a specific area of the nerve. The sound waves cause a break in the nerve which carries pain signals. Sound waves transmit through the skin so there is no need for needles. The procedure takes approximately one hour. The device has been approved in Health Canada and Europe for the treatment of lower back pain. This study is to evaluate the use of the same device for people in Canada who have knee pain related to osteoarthritis.

A vizsgálat csoportja

  • Thermal ablation with Neurolyser XRA vizsgált kezelés

    Ablation of sensory nerves in the knee joint

    Kezelés: Neurotomy of the medial sensory articular branches

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Safety and Feasibility of the Neurolyser XR Device for the Treatment of Predominantly Medial Chronic Knee Pain Due to Osteoarthritis
A regiszteradat frissítve
2026. november 9.